IRIS
RIPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.910
AS - Asia 2.036
NA - Nord America 1.893
SA - Sud America 421
AF - Africa 65
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.773
RU - Federazione Russa 1.709
SG - Singapore 645
CN - Cina 643
IT - Italia 344
BR - Brasile 317
SE - Svezia 294
HK - Hong Kong 281
VN - Vietnam 183
DE - Germania 128
GB - Regno Unito 105
FR - Francia 101
CA - Canada 76
IN - India 68
FI - Finlandia 43
AR - Argentina 41
PL - Polonia 39
AU - Australia 32
JP - Giappone 31
AT - Austria 30
MX - Messico 30
NL - Olanda 30
BD - Bangladesh 26
ES - Italia 24
ZA - Sudafrica 20
TR - Turchia 19
PK - Pakistan 17
SA - Arabia Saudita 17
ID - Indonesia 15
CO - Colombia 14
IQ - Iraq 14
EC - Ecuador 12
IR - Iran 12
TN - Tunisia 12
UA - Ucraina 11
CL - Cile 10
MA - Marocco 9
PH - Filippine 9
VE - Venezuela 9
BE - Belgio 8
PY - Paraguay 8
EG - Egitto 7
IE - Irlanda 7
KR - Corea 7
LT - Lituania 7
LU - Lussemburgo 7
TW - Taiwan 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
PT - Portogallo 6
UY - Uruguay 6
HR - Croazia 5
KE - Kenya 5
CY - Cipro 4
MY - Malesia 4
CH - Svizzera 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
MK - Macedonia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
LR - Liberia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 7.358
Salva come PNG Salva come JPEG
Città #
Singapore 359
Moscow 313
Hong Kong 273
Ashburn 265
Dallas 229
San Jose 159
Beijing 132
New York 127
Shanghai 120
Hefei 78
Milan 77
Los Angeles 69
Lauterbourg 68
Ho Chi Minh City 63
Lawrence 60
Princeton 59
Boardman 47
São Paulo 44
Munich 38
Hanoi 36
Orem 34
Warsaw 33
Montreal 30
Denver 28
Chennai 27
Tokyo 27
Helsinki 26
Rome 25
London 23
Nuremberg 21
Santa Clara 21
Cesano Boscone 20
Poplar 20
Atlanta 19
Houston 19
Seattle 18
Toronto 18
Genoa 17
Stockholm 17
Council Bluffs 16
Brooklyn 15
Mexico City 15
Guangzhou 14
Rio de Janeiro 14
Turku 13
Da Nang 12
Johannesburg 11
Manchester 11
Tianjin 11
Washington 11
Wollongong 10
Amsterdam 9
Boston 9
Falkenstein 9
Frankfurt am Main 9
Lahore 9
Mumbai 9
Phoenix 9
San Francisco 9
Turin 9
Verona 9
Ankara 8
Baghdad 8
Barnet 8
Brisbane 8
Chicago 8
Huskvarna 8
Naples 8
The Dalles 8
Vienna 8
Belo Horizonte 7
Columbus 7
Curitiba 7
Istanbul 7
Kassel 7
Madrid 7
Sydney 7
Tashkent 7
Bogotá 6
Brasília 6
Brussels 6
Catania 6
Haiphong 6
Melbourne 6
Montevideo 6
Pune 6
Querétaro 6
Riyadh 6
Caruaru 5
Jeddah 5
Nairobi 5
Padova 5
Quezon City 5
Santiago 5
Vancouver 5
Vittoria 5
Yongin-si 5
Zagreb 5
Assago 4
Buenos Aires 4
Totale 3.548
Salva come PNG Salva come JPEG
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 225
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Biobanking for COVID-19 research 144
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 142
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 142
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 140
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 138
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 130
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 128
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 122
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 120
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 117
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 114
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 111
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 108
Subclinical myocardial dysfunction in patients recovered from COVID-19 107
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 106
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 106
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 105
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 105
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 104
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 103
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 102
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 100
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 98
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 97
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 97
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 97
Ceftobiprole for the treatment of infective endocarditis: A case series 95
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 95
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 91
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 90
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 90
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 89
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 89
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 89
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 88
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 87
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 86
Comprehensive CT study to assess local and systemic involvement in patients with infective endocarditis: experience from a multidisciplinary team of a tertiary referral center 85
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 83
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 82
How do I manage a patient with Stenotrophomonas maltophilia infection? 81
Bowel perforation in a Covid-19 patient: case report 80
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 77
Immunosenescence and hurdles in the clinical management of older HIV-patients 70
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 70
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 68
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 67
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 66
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 66
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 66
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 65
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 63
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 63
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 62
Eosinophils from Physiology to Disease: A Comprehensive Review 59
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 59
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 59
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 59
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 58
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 57
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 56
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 56
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 55
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 55
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 54
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 54
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 53
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 52
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 52
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 52
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 51
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 51
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 51
Rugarli. Medicina interna sistematica 48
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 43
Bridging the gap in bloodstream infection management: A survey among non-infectious disease physicians 42
Rugarli. Medicina interna sistematica 42
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research 26
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 6
Totale 7.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/2022151 1 0 3 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/20251.433 116 39 41 71 72 146 169 190 195 120 99 175
2025/20264.893 373 276 296 658 486 194 379 442 1.486 303 0 0
Totale 7.544